Back

Chronic administration of Empagliflozin induces cardioprotection in vivo in absence of diabetes mellitus

2 September 2019 (14:00 - 18:00)
Organised by:
Congress Presentation Part of: Poster Session 5 - Mechanisms underlying pharmacotherapy Antidiabetic Pharmacotherapy ESC Premium Access ESC Congress 2019

About the speaker

Photo
Doctor Panagiota Efstathia Nikolaou

National & Kapodistrian University of Athens, Athens (Greece)

6 More presentations in this session

Presentation thumbnail
Assistant Professor K. Saavedra (Temuco, CL)
Abstract
Presentation thumbnail
Doctor O. Perez-Mendez (Mexico City, MX)
Abstract Slides
Presentation thumbnail
Miss T. Kasi Ganeshan (London, GB)
Abstract
Presentation thumbnail
Miss C. Almenglo (Santiago de Compostela, ES)
Abstract Slides
Presentation thumbnail
Doctor C. del Rio (Brisbane, US)
Abstract

Access the full session

Session thumbnail
Poster Session 5 - Mechanisms underlying pharmacotherapy

The Event

Event poster

ESC Congress 2019

2 September 2019 14:00 CET
You may be interested in
thumbnail
Congress Session
Guidelines in Practice: 2023 ESC Guidelines for the Management of Cardiovascular Disease in Patients with Diabetes
thumbnail
Congress Presentation
Antithrombotic therapy in diabetes
thumbnail
Congress Session
2023 ESC Guidelines for the Management of Cardiovascular Disease in Patients with Diabetes

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources